Skip to main content

Table 2 Patient demographics

From: A randomized trial of supplemental parenteral nutrition in underweight and overweight critically ill patients: the TOP-UP pilot trial

Characteristic

EN only (n = 73)

SPN + EN (OLIMEL) (n = 52)

Age, yrs

55.1 ± 16.2

55.8 ± 19.8

Sex

 Male

39 (53.4%)

21 (40.4%)

 Female

34 (46.6%)

31 (59.6%)

APACHE II score

20.8 ± 7.2

20.5 ± 6.4

Baseline SOFA score

5.9 ± 3.6

6.2 ± 3.5

NUTRIC score

3.8 ± 2.1

3.9 ± 1.9

Barthel Index baseline

88.1 ± 22.7

91.3 ± 11.7

BMI

33.2 ± 15.0

33.5 ± 14.9

BMI groups

  < 25

38 (52.1%)

27 (51.9%)

  > 35

35 (47.9%)

25 (48.1%)

Ethnicity

 White

65 (89.0%)

46 (88.5%)

 Black or African American

4 (5.5%)

2 (3.8%)

 Native Hawaiian or Pacific Islander

2 (2.7%)

0 (0.0%)

 Native

2 (2.7%)

0 (0.0%)

 Unknown/not reported

0 (0.0%)

4 (7.7%)

 Charlson Comorbidity Index

1.7 ± 1.9

1.3 ± 1.7

Type of admission

 Medical

43 (58.9%)

31 (59.6%)

 Surgical

30 (41.1%)

21 (40.4%)

Primary diagnosis

 Respiratory

24 (32.9%)

13 (25.0%)

 Sepsis

18 (24.7%)

15 (28.8%)

 Gastrointestinal

9 (12.3%)

6 (11.5%)

 Neurologic

9 (12.3%)

5 (9.6%)

 Other

4 (5.5%)

1 (1.9%)

 Trauma

3 (4.1%)

0 (0.0%)

 Metabolic

3 (4.1%)

0 (0.0%)

 Cardiovascular/vascular

3 (4.1%)

11 (21.2%)

 Hematologic

0 (0.0%)

1 (1.9%)

  1. Continuous variables are reported as mean ± standard deviation, and categorical variables are reported as count (% of column total)
  2. Abbreviations: APACHE II Acute Physiology and Chronic Health Evaluation II, BMI body mass index, EN enteral nutrition, NUTRIC Nutrition Risk in Critically Ill, SOFA Sequential Organ Failure Assessment, SPN supplemental parenteral nutrition